Interpace Biosciences, Inc. (IDXG)
1.43
-0.09
(-6.09%)
USD |
OTCM |
Aug 24, 16:00
Interpace Biosciences Shareholders Equity (Quarterly) : 23.24M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.24M |
| March 31, 2026 | 23.08M |
| December 31, 2025 | 22.36M |
| September 30, 2025 | -0.298M |
| June 30, 2025 | -1.213M |
| March 31, 2025 | -0.582M |
| December 31, 2024 | -2.217M |
| September 30, 2024 | -11.15M |
| June 30, 2024 | -12.49M |
| March 31, 2024 | -14.60M |
| December 31, 2023 | -9.003M |
| September 30, 2023 | -16.14M |
| June 30, 2023 | -15.67M |
| March 31, 2023 | -16.00M |
| December 31, 2022 | -16.54M |
| September 30, 2022 | -15.06M |
| June 30, 2022 | -1.416M |
| March 31, 2022 | 2.195M |
| December 31, 2021 | 4.118M |
| September 30, 2021 | 7.888M |
| June 30, 2021 | 10.74M |
| March 31, 2021 | 13.64M |
| December 31, 2020 | 17.45M |
| September 30, 2020 | 24.74M |
| June 30, 2020 | 30.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.64M |
| December 31, 2019 | 21.69M |
| September 30, 2019 | 36.76M |
| June 30, 2019 | 30.83M |
| March 31, 2019 | 35.77M |
| December 31, 2018 | 32.94M |
| September 30, 2018 | 36.03M |
| June 30, 2018 | 38.55M |
| March 31, 2018 | 39.76M |
| December 31, 2017 | 39.87M |
| September 30, 2017 | 36.38M |
| June 30, 2017 | 36.34M |
| March 31, 2017 | 24.57M |
| December 31, 2016 | 6.531M |
| September 30, 2016 | -1.479M |
| June 30, 2016 | 5.993M |
| March 31, 2016 | 8.306M |
| December 31, 2015 | |
| September 30, 2015 | 5.861M |
| June 30, 2015 | 10.30M |
| March 31, 2015 | 16.62M |
| December 31, 2014 | 20.12M |
| September 30, 2014 | 25.42M |
| June 30, 2014 | 29.35M |
| March 31, 2014 | 31.34M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.3419M |
| Xcelerate, Inc. | -2.102M |
| Vivos Therapeutics, Inc. | -3.815M |
| Hinge Health, Inc. | 344.33M |
| PD-Rx Pharmaceuticals, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.55M |
| Total Liabilities (Quarterly) | 11.30M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 2.215 |
| Net Debt Paydown Yield | 1.45% |